BIO-key International Beheer

Beheer criteriumcontroles 4/4

De CEO BIO-key International is Mike DePasquale, benoemd in Jan2003, heeft een ambtstermijn van 21.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 291.53K, bestaande uit 93% salaris en 7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.99% van de aandelen van het bedrijf, ter waarde $ 48.44K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.8 jaar en 7.6 jaar.

Belangrijke informatie

Mike DePasquale

Algemeen directeur

US$291.5k

Totale compensatie

Percentage CEO-salaris	93.0%
Dienstverband CEO	21.8yrs
Eigendom CEO	2.0%
Management gemiddelde ambtstermijn	7.8yrs
Gemiddelde ambtstermijn bestuur	7.6yrs

Recente managementupdates

Recent updates

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

Aug 12

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

Jun 12

BIO-key International, Inc.'s (NASDAQ:BKYI) Shift From Loss To Profit

Feb 28

Analyse CEO-vergoeding

Hoe is Mike DePasquale's beloning veranderd ten opzichte van BIO-key International's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-US$6m
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	US$292k	US$271k	-US$9m
Sep 30 2023	n/a	n/a	-US$12m
Jun 30 2023	n/a	n/a	-US$14m
Mar 31 2023	n/a	n/a	-US$13m
Dec 31 2022	US$372k	US$296k	-US$12m
Sep 30 2022	n/a	n/a	-US$7m
Jun 30 2022	n/a	n/a	-US$6m
Mar 31 2022	n/a	n/a	-US$5m
Dec 31 2021	US$277k	US$275k	-US$5m
Sep 30 2021	n/a	n/a	-US$4m
Jun 30 2021	n/a	n/a	-US$7m
Mar 31 2021	n/a	n/a	-US$7m
Dec 31 2020	US$349k	US$275k	-US$10m
Sep 30 2020	n/a	n/a	-US$18m
Jun 30 2020	n/a	n/a	-US$16m
Mar 31 2020	n/a	n/a	-US$16m
Dec 31 2019	US$311k	US$275k	-US$15m
Sep 30 2019	n/a	n/a	-US$6m
Jun 30 2019	n/a	n/a	-US$8m
Mar 31 2019	n/a	n/a	-US$8m
Dec 31 2018	US$333k	US$275k	-US$8m
Sep 30 2018	n/a	n/a	-US$7m
Jun 30 2018	n/a	n/a	-US$6m
Mar 31 2018	n/a	n/a	-US$6m
Dec 31 2017	US$843k	US$250k	-US$5m

Compensatie versus markt: De totale vergoeding ($USD 291.53K ) Mike } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 656.26K ).

Compensatie versus inkomsten: De vergoeding van Mike is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Mike DePasquale (69 yo)

21.8yrs

Tenure

US$291,527

Compensatie

Mr. Michael W. DePasquale, also known as Mike, has been the Chief Executive Officer of BIO-key International Inc. since January 3, 2003. He has been the Chairman and Director of BIO-key International Inc....

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Michael DePasquale	Chairman & CEO	21.8yrs	US$291.53k	1.99% $ 48.4k
Cecilia Welch	Chief Financial Officer	14.9yrs	US$207.70k	0.096% $ 2.3k
James Sullivan	Senior VP of Strategy & Compliance and Chief Legal Officer	4.8yrs	US$235.41k	2.25% $ 54.8k
Mira LaCous	Chief Technology Officer	10.7yrs	US$240.43k	0.53% $ 12.9k
Akintunde Jeje	Managing Director of Africa	4.8yrs	geen gegevens	geen gegevens
Alex Rocha	Managing Director of EMEA	2.5yrs	geen gegevens	geen gegevens
Mark Cochran	President of PortalGuard	no data	geen gegevens	geen gegevens

7.8yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BKYI is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Michael DePasquale	Chairman & CEO	21.8yrs	US$291.53k	1.99% $ 48.4k
Cameron Williams	Independent Director	1.4yrs	US$4.00k	0.31% $ 7.7k
Robert Michel	Independent Director	7.6yrs	US$11.00k	0.40% $ 9.7k
Kwok Fong Wong	Vice-Chairman of the Board	8.9yrs	geen gegevens	1.58% $ 38.6k
Emmanuel Alia	Independent Director	4.6yrs	US$10.00k	0.35% $ 8.4k

7.6yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BKYI wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).

BIO-key International Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

BIO-key International, Inc., Annual General Meeting, Aug 22, 2024

BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of Directors

BIO-key International, Inc., Annual General Meeting, Jul 24, 2023

Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of Directors

Insufficient new directors

BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of Directors

Recent updates

Price target decreased by 40% to US$3.00

BIO-key®International, Inc.'s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Now Available on the Amazon Web Services Marketplace

BIO-key International, Inc. to Report Q2, 2024 Results on Aug 14, 2024

BIO-key International, Inc., Annual General Meeting, Aug 22, 2024

BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. announced delayed annual 10-K filing

BIO-key International, Inc. to Report Q4, 2023 Results on Apr 02, 2024

Forecast to breakeven in 2024

BIO-key International, Inc. announced that it has received $0.547726 million in funding from Dillon Hill Capital, LLC

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of Directors

Price target decreased by 25% to US$1.50

BIO-key International, Inc. has completed a Composite Units Offering in the amount of $3.75025 million.

BIO-key International, Inc. announced delayed 10-Q filing

Price target decreased by 60% to US$2.00

BIO-key International, Inc. to Report Q2, 2023 Results on Aug 14, 2023

BIO-Key International Receives a Letter from Nasdaq

BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its First Quarter 2023 Form 10-Q with SEC

BIO-key International, Inc., Annual General Meeting, Jul 24, 2023

Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of Directors

BIO-key International Receives Notice of Non-Compliance from Nasdaq

BIO-key International, Inc. announced delayed 10-Q filing

First quarter 2023 earnings released: US$0.057 loss per share (vs US$0.13 loss in 1Q 2022)

BIO-key International, Inc. to Report Q1, 2023 Results on May 15, 2023

Insufficient new directors

BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of Directors

BIO-key Receives Nasdaq Notification Regarding $1.00 Minimum Closing Bid Price Requirement

Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue Officer

BIO-key International, Inc. announced that it has received $2.2 million in funding from AJB Investment Management, LLC

Price target decreased to US$4.00

Insufficient new directors

BIO-Key International, Inc. Provides Revenue Guidance for the Year 2022

BIO-key International, Inc. to Report Q3, 2022 Results on Nov 14, 2022

BIO-key International, Inc. Showcases PortalGuard Identity and Access Management Platform for Higher Education at EDUCAUSE Annual Conference October 25-28

BIO-key International, Inc. Launches Mobile Authenticator with Server-Secured and On-Device Multi-Biometric Methods to Be Showcased At 2022 Gartner IAM Summit

BIO-key International, Inc. announced delayed 10-Q filing

Insufficient new directors

BIO-key International, Inc. Provides Financial Guidance for Full-Year 2022

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

BIO-key International, Inc. to Report Q2, 2022 Results on Aug 12, 2022

BIO-key Showcases Biometric Cybersecurity Solutions at MSP Expo Florida (Booth 536) to Support its Growing Distribution Base of Managed Service Providers

BIO-key International, Inc. announced delayed 10-Q filing

BIO-key International, Inc. to Report Q1, 2022 Results on May 16, 2022

BIO-key International, Inc., Annual General Meeting, Jun 24, 2022

BIO-key International, Inc. announced delayed annual 10-K filing

Bio-Key International, Inc. Provides Earnings Guidance for the Full Year 2022

Full year 2021 earnings released: US$0.65 loss per share (vs US$2.08 loss in FY 2020)

BIO-key International, Inc. (NasdaqCM:BKYI) signed a definitive agreement to acquire Swivel Secure Europe, S.A.

Bio-Key International, Inc. Launches Enhanced Admin Panel and User Experience for IT Teams Managing Its Portalguard Identity-As-A-Service (IDaaS) Solution

Insufficient new directors

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.51 loss in 3Q 2020)

BIO-key International, Inc Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors

Forecast to breakeven in 2022

BIO-key International, Inc. Announces Improved Next-Generation EcoID II USB Compact Fingerprint Scanner

BIO-Key International, Inc. Confirms Revenue Guidance for the Full Year 2021

Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.60 loss in 2Q 2020)

Bio-Key Introduces SSO Concierge™ to Its Portalguard Identity & Access Management Platform, Eliminating Passwords for Thick Client Applications

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

First quarter 2021 earnings released: US$0.094 loss per share (vs US$1.84 loss in 1Q 2020)

BIO-key International, Inc Provides Earnings Guidance for the Year 2021

BIO-Key International, Inc. Introduces BIO-key MobileAuth

BIO-key International, Inc. Provides Earnings Guidance for the Fiscal 2021

Full year 2020 earnings released: US$2.08 loss per share (vs US$8.10 loss in FY 2019)

BIO-key International, Inc. to Report Fiscal Year 2020 Results on Mar 25, 2021

BIO-key International, Inc.'s (NASDAQ:BKYI) Shift From Loss To Profit

West Coast State Election Office Expands Bio-Key International, Inc.'s Biometric Multi-Factor Authentication Solution

BIO-key International, Inc. Announces Partnership With Appsian to Provide Advanced Authentication Security to Enterprise Resource Planning (ERP) Applications